Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
B
Details...
Enter Symbol
Gilead Sciences, Inc. (NASDAQ: GILD)
Sector: Medical
Current Price :
$50.49
52 Week Low
$35.34
52 Week High
$56.03
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
758M
Market Cap:
$37.83B
Avg Volume:
8036246
P/E Ratio:
14.460
PEG Ratio:
0.890
Split:
On 6/25/2007 gild split by factor of 2.000
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
Gilead Sciences (GILD): FDA Advisory Committee Supports Approval Of Quad To Treat HIV-1
May 11, 2012 06:58 PM |
GILD
U.S. Futures Fall After JPMorgan's Trading Loss; Hot Stocks: NVDA, JPM, GILD, ESRX, JWN, C, BAC, MS, GS, WFC
May 11, 2012 09:12 AM |
BAC
,
C
,
ESRX
,
GILD
,
GS
,
JPM
Gilead Sciences' HIV Pill To Undergo FDA Panel Review
May 10, 2012 10:40 AM |
ABT
,
GILD
Gilead’s Hematology Pipeline - Transformative And Under-Appreciated
May 09, 2012 10:45 AM |
EXEL
,
GILD
,
INCY
,
NVS
,
PCYC
,
RIGL
U.S. Stocks Retreat Amid Mixed Economic Data, Earnings;Hot Stocks: MSFT, SNDK, EBAY, QCOM, GILD, HGSI, CY, FFIV
Apr 19, 2012 04:57 PM |
BMY
,
CY
,
EBAY
,
FFIV
,
GILD
,
GSK
More Articles on GILD..
Market News
HP, Campbell Soup, Zale are big market movers
Nov 22, 2011 04:54 PM |
CHS
,
CPB
,
GILD
,
HPQ
,
MDT
,
PSS
Lack of progress on debt deal saps confidence
Nov 21, 2011 11:55 PM |
BAC
,
GILD
,
HPQ
The supercommittee sell-off: Dow loses almost 250
Nov 21, 2011 04:53 PM |
BA
,
CBE
,
GILD
,
HPQ
,
MCO
,
TRH
Stocks plunge as debt talks near collapse
Nov 21, 2011 02:10 PM |
BA
,
GILD
,
MCO
,
TRH
,
VRUS
,
Y
Stocks plunge as debt talks near collapse
Nov 21, 2011 11:51 AM |
GILD
,
HPQ
,
TRH
,
VRUS
,
Y
More News on GILD..
Press Releases
Gilead Files European Marketing Application for Boosting Agent Cobicistat
May 23, 2012 04:05 PM |
GILD
FDA Advisory Committee Supports Approval of Gilead's Once-Daily Quad Single Tablet Regimen for HIV
May 11, 2012 03:31 PM |
GILD
FDA Advisory Committee Supports Approval of Gilead's Truvada? for Reducing the Risk of Acquiring HIV
May 10, 2012 08:35 PM |
GILD
More Press Releases on GILD..
SEC Filings
Form 4 GILEAD SCIENCES INC For: May 12 Filed by: DENNY JAMES M (10K)
May 15, 2012 08:59 PM
Form 4 GILEAD SCIENCES INC For: May 12 Filed by: HILLS CARLA A (10K)
May 15, 2012 08:59 PM
Form 4 GILEAD SCIENCES INC For: May 12 Filed by: Cogan John Francis (10K)
May 15, 2012 08:58 PM
More SEC Filings on GILD..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
GILD
Compare to S&P
YTD
21.92 %
12.82 %
4 Weeks
7.10 %
8.09 %
12 Weeks
-9.11 %
-10.29 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-33.70 %
EPS Growth in Last Year:
-25.61 %
Sales Growth in Last Quarter:
3.73 %
Sales Growth in Last Quarter:
18.50 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##